AfterRaise/Companies/Zarminali Pediatrics

Zarminali Pediatrics

Zarminali Pediatrics is a provider of an outpatient pediatric destination purpose-built to provide integrated primary and specialty care nationwide. From its funding announcement.

$110M Series ARaised 9 months agoChicago, USAHealthcare & MedtechUSA
Visit website →

In their own words

What Zarminali Pediatrics says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "provider of an outpatient pediatric destination purpose-built to provide integrated primary and specialty care nationwide". Source

Market expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where Zarminali Pediatrics is today

Zarminali Pediatrics announced a Series A round of $110M on 21 January 2026, led by Healthier Capital.

Latest round
Series A
Amount
$110M
Announced
21 January 2026
Headquarters
Chicago, USA
Sector
Healthcare & Medtech
Investors
Also participating
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

46
Steady growth
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
22/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 21 January 2026
    $110M Series A
    Led by Healthier Capital.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Aggressive multi-front expansion

Opportunities this could create

  • Provider partnerships
  • Market-entry advisers
  • Local employment infrastructure
  • In-market partnerships
  • Clinical evidence

Based on the Healthcare & Medtech sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Early momentum2 connected signals
  • 21 January 2026$110M Series A announced
  • 21 January 2026Stated priority: market expansion

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Zarminali Pediatrics is open to

Not yet specified

Zarminali Pediatrics has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Zarminali Pediatrics

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Zarminali Pediatrics?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector